Search results
With 'functional' beverages, brands rush to quench a thirst for drinks that do more than just taste...
Chicago Sun-Times· 5 days agoSupermarket beverage aisles are starting to look a lot more like a pharmacy. There are sodas made...
Is Whole Wheat Bread Good for You? 8 Effects of Eating It
Eat This, Not That! via AOL· 2 days agoPhoto: Shutterstock/mama_mia. Design: Eat This, Not That!Bread has gotten a bad reputation, and as a...
Pop a daily aspirin to prevent colorectal tumors? New research strengthens case
FierceBiotech· 6 days agoCould your daily aspirin prevent colorectal tumors? Researchers from the University Hospital of Padova in Italy described how they found that patients with colorectal cancer
Novartis lifts guidance after first-quarter results beat expectations
CNBC· 6 days agoIt has previously predicted that adjusted operating income would increase by a "high single-digit"...
Novartis lifts guidance after Q1 results beat expectations
Reuters· 6 days agoIt has previously predicted that adjusted operating income would increase by a "high single-digit"...
Novartis raises guidance after beating Q1 expectations By Reuters
Investing.com· 6 days agoFRANKFURT (Reuters) -Swiss drugmaker Novartis (LON:0QLR) raised its full-year guidance on wider use...
Novartis Investors to Eye Outlook, Key Drugs at Earnings -- Earnings Preview
Market Watch· 7 days agoNovartis is scheduled to report results for the first quarter on Tuesday. --CORE OPERATING PROFIT: The Swiss pharmaceutical major is set to book $4.245 billion in core operating profit--one ...
UPDATE 4-Novartis raises guidance after beating Q1 expectations
Reuters via Yahoo Finance· 6 days agoSwiss drugmaker Novartis raised its full-year guidance on wider use of psoriasis and arthritis drug Cosentyx on Tuesday and said it had tapped the former boss of Bristol Myers Squibb (BMS) to ...
From yawning to stomach cramps - Dr Zoe Williams answers your health questions
The US Sun· 6 days agoDehydration is something many Brits are living with, without even realising it – it might explain...
Lantheus (NASDAQ:LNTH) Price Target Raised to $99.00
ETF DAILY NEWS· 7 days agoThe brokerage currently has a buy rating on the medical equipment provider’s stock. Truist Financial reissued a buy rating and issued a $82.00 target price (up previously from $80.00) on shares ...